A Formulation Comprising Polyclonal Igy Antibodies

Abstract: The invention is related to a formulation comprising of a polyclonal IgY antibodies of SARS CoV2-and a pharmaceutical acceptable carrier, wherein the polyclonal IgY antibodies is in the range of 50- 200 mg (w/v) and wherein the polyclonal IgY antibodies is a lyophilised powder. The formulation is one of nasal spray or a mouth gargle to be used as a prophylaxis and therapeutic formulation against COVID 19. This invention also includes formulation of IgY as enteric coated tablet to neutralize the effect of virus in the intestinal tract. The virus neutralization titer of the formulation is in the range of 1: 3200 - 1: 51200. The polyclonal IgY antibodies neutralizes the SARS CoV 2 virus.

Patent Information

Application #

Filing Date

05 June 2020

Publication Number

50/2021

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

ipo@knspartners.com

Parent Application

Applicants

CISGEN BIOTECH DISCOVERIES PRIVATE LIMITED

A133, Ankur Palm Springs, No 4, CTH Road, Padi, Chennai 600050, Tamil Nadu, India

Inventors

1. MOHANA SUBRAMANIAN BHASKARAN

Cisgen Biotech Discoveries Private Limited, A133, Ankur Palm Springs, No 4, CTH Road, Padi, Chennai 600050, Tamil Nadu, India

2. MAROUDAM VEERASAMI

Cisgen Biotech Discoveries Private Limited, A133, Ankur Palm Springs, No 4, CTH Road, Padi, Chennai 600050, Tamil Nadu, India

3. HARINI DHANDAPANI

Cisgen Biotech Discoveries Private Limited, A133, Ankur Palm Springs, No 4, CTH Road, Padi, Chennai 600050, Tamil Nadu, India

4. JANANI KRISHNAKUMAR

Cisgen Biotech Discoveries Private Limited, A133, Ankur Palm Springs, No 4, CTH Road, Padi, Chennai 600050, Tamil Nadu, India

Specification

DESC:PLEASE SEE THE ATTACHMENT ,CLAIMS:PLEASE SEE THE ATTACHMENT

Documents

Application Documents

#	Name	Date
1	202041015027-COMPLETE SPECIFICATION [03-06-2021(online)].pdf	2021-06-03
1	202041015027-STATEMENT OF UNDERTAKING (FORM 3) [05-04-2020(online)].pdf	2020-04-05
2	202041015027-PROVISIONAL SPECIFICATION [05-04-2020(online)].pdf	2020-04-05
2	202041015027-CORRESPONDENCE-OTHERS [03-06-2021(online)].pdf	2021-06-03
3	202041015027-FORM FOR STARTUP [05-04-2020(online)].pdf	2020-04-05
3	202041015027-DRAWING [03-06-2021(online)].pdf	2021-06-03
4	202041015027-APPLICATIONFORPOSTDATING [31-03-2021(online)].pdf	2021-03-31
4	202041015027-FORM FOR SMALL ENTITY(FORM-28) [05-04-2020(online)].pdf	2020-04-05
5	202041015027-PostDating-(31-03-2021)-(E-6-85-2021-CHE).pdf	2021-03-31
5	202041015027-FORM 1 [05-04-2020(online)].pdf	2020-04-05
6	202041015027-FORM-26 [11-05-2020(online)].pdf	2020-05-11
6	202041015027-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [05-04-2020(online)].pdf	2020-04-05
7	202041015027-Proof of Right [06-04-2020(online)].pdf	2020-04-06
7	202041015027-DECLARATION OF INVENTORSHIP (FORM 5) [05-04-2020(online)].pdf	2020-04-05
8	202041015027-Proof of Right [06-04-2020(online)].pdf	2020-04-06
8	202041015027-DECLARATION OF INVENTORSHIP (FORM 5) [05-04-2020(online)].pdf	2020-04-05
9	202041015027-FORM-26 [11-05-2020(online)].pdf	2020-05-11
9	202041015027-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [05-04-2020(online)].pdf	2020-04-05
10	202041015027-FORM 1 [05-04-2020(online)].pdf	2020-04-05
10	202041015027-PostDating-(31-03-2021)-(E-6-85-2021-CHE).pdf	2021-03-31
11	202041015027-APPLICATIONFORPOSTDATING [31-03-2021(online)].pdf	2021-03-31
11	202041015027-FORM FOR SMALL ENTITY(FORM-28) [05-04-2020(online)].pdf	2020-04-05
12	202041015027-FORM FOR STARTUP [05-04-2020(online)].pdf	2020-04-05
12	202041015027-DRAWING [03-06-2021(online)].pdf	2021-06-03
13	202041015027-PROVISIONAL SPECIFICATION [05-04-2020(online)].pdf	2020-04-05
13	202041015027-CORRESPONDENCE-OTHERS [03-06-2021(online)].pdf	2021-06-03
14	202041015027-STATEMENT OF UNDERTAKING (FORM 3) [05-04-2020(online)].pdf	2020-04-05
14	202041015027-COMPLETE SPECIFICATION [03-06-2021(online)].pdf	2021-06-03